Capacity Crunch in Gene Therapy? Our Expansion Comes at the Perfect Time.

As global demand for gene therapy manufacturing soars, we’re seeing a growing strain on capacity,…

Big Moves Start with Bold Partners

At Tailored Genes, we believe that every scientific breakthrough starts with a partnership built on…

Gene Therapy is Changing Cancer Treatment

Traditional cancer treatments, including chemotherapy and radiation, have long been the standard of care. However,…

Canada’s Growing Biomanufacturing Sector: The Critical Role of Viral Vectors

Canada is rapidly emerging as a global powerhouse in biomanufacturing, with increased investment in research,…

Canada’s Biotech Ecosystem is Thriving: Tailored Genes is Leading the Way

The recent announcement of AstraZeneca’s C$820 million investment in Canada is a testament to the…

Gene therapy for primary immune deficiencies: a Canadian perspective

Abstract The use of gene therapy (GT) for the treatment of primary immune deficiencies (PID)…

Tailored Genes Breaks New Ground to build Full-Service Viral vector Facility in Vaughan

In an era where speed, precision, and innovation are redefining the boundaries of science, Tailored…

Innovative Gene Therapy Innovation Finds New Home In Vaughan – To Open 5000 Sq Ft Facility To “Advance Gene Therapy Innovation.”

Vaughan, Ontario, Date:21- May-2025 Something big is going on in Vaughan, Ontario. Biotech company Tailored…

For Immed Release : Canadian Biotech Tailored Genes Secures over $1M Federal Investment to Scale Gene Therapy Production

 Toronto, ON, October 21, 2025 The Government of Canada, through the Federal Economic Development Agency…